JPMORGAN CHASE & CO - REPROS THERAPEUTICS INC ownership

REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 62 filers reported holding REPROS THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of REPROS THERAPEUTICS INC
ValueSharesWeighting
Q2 2016$45,000
+164.7%
27,750
+55.2%
0.00%
Q1 2016$17,000
-15.0%
17,877
+7.4%
0.00%
Q4 2015$20,000
-74.7%
16,643
+50.4%
0.00%
Q2 2015$79,000
-92.1%
11,068
-79.7%
0.00%
Q4 2013$996,000
-37.8%
54,391
-9.0%
0.00%
Q3 2013$1,602,000
-56.8%
59,757
-70.2%
0.00%
-100.0%
Q2 2013$3,706,000200,8050.00%
Other shareholders
REPROS THERAPEUTICS INC shareholders Q3 2015
NameSharesValueWeighting ↓
Sarissa Capital Management LP 1,132,367$9,727,0002.05%
RTW INVESTMENTS, LP 229,364$1,970,0000.89%
PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC 361,300$3,104,0000.85%
DESTRIER CAPITAL MANAGEMENT LLC 329,030$2,826,0000.73%
SENZAR ASSET MANAGEMENT, LLC 244,006$2,096,0000.51%
GENERAL AMERICAN INVESTORS CO INC 508,375$4,367,0000.36%
CQS Cayman LP 700,000$6,013,0000.28%
Rotella Capital Management, Inc. 20,800$179,0000.15%
Baker Brothers Advisors 2,000,000$17,180,0000.14%
Gruss Capital Management LP 304,000$2,611,0000.11%
View complete list of REPROS THERAPEUTICS INC shareholders